ELEVIDYS is a prescription gene therapy used to treat ambulatory and non-ambulatory people with Duchenne muscular dystrophy who are at least 4 years old and have a confirmed …

Delandistrogene moxeparvovec, sold under the brand name Elevidys, is a recombinant gene therapy used for the treatment of Duchenne muscular dystrophy. [3] It is designed to deliver …

4. Visually inspect each vial of ELEVIDYS. ELEVIDYS is a clear, colorless liquid that may have some opalescence. ELEVIDYS may contain white to off-white particles.

Apr 11, 2025 · Elevidys is a gene therapy used for Duchenne muscular dystrophy (DMD) to improve motor function and strengthen muscles. Elevidys works by helping the body produce …

3 days ago · Suspending all commercial shipments of ELEVIDYS for non-ambulatory patients while an enhanced safety protocol is reviewed. Convening an independent panel of experts in …

Aug 9, 2024 · Elevidys (delandistrogene moxeparvovec) is a prescription gene therapy that’s used to treat Duchenne muscular dystrophy. Elevidys is a single-dose treatment that’s given as an …

ELEVIDYS is indicated for the treatment of Duchenne muscular dystrophy (DMD) in individuals at least 4 years of age: For patients who are ambulatory and have a confirmed mutation in the …

2 days ago · ELEVIDYS (delandistrogene moxeparvovec-rokl) is a single-dose, adeno-associated virus (AAV)-based gene transfer therapy for intravenous infusion designed to address the …

ELEVIDYS (delandistrogene moxeparvovec-rokl) is a recombinant gene therapy designed to deliver the gene encoding the ELEVIDYS micro-dystrophin protein. ELEVIDYS is a non …

Jul 31, 2024 · Elevidys (delandistrogene moxeparvovec-rokl) is commonly used to treat Duchenne muscular dystrophy (DMD). DMD is a progressive, genetic disease that affects muscles, …